Aptamers Market: Microfluidic SELEX Discovery, Chemical Antibodies, and Targeted Therapeutics Driving Growth
Accelerating demand for high-specificity molecular recognition ligands, expanding commercial approvals for ophthalmic and oncology nucleic acid drugs, and continuous technological breakthroughs in automated selection platforms are driving rapid growth across the global Aptamers Market. Aptamers—comprising single-stranded DNA, RNA, or xeno-nucleic acid (XNA) oligonucleotides folded into...
0 Commenti 0 condivisioni 4 Views 0 Anteprima